Replimune Group, Inc.
- Last sale
- Nov 12, 2026 · +1.01%
- Market cap
- $2.08B
- 94.8M shares
- Filings
- 663
Q3 2018
—Q2 2027N/M FY26 yoy
Q2 2027N/M FY26 yoy
Q2 2027derivedN/M FY26 yoy
Q2 2027N/M FY26 yoy
Q2 2027+88.1% FY26 yoy
- $2.08B
- —
- —
- 10.2×
- -13.66%
- —
FY2026 figures · derived
Price
Nov 12, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Research And Development
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2026 | 2026-03-31 | $221,184,000 | reported | |
| FY 2025 | 2025-03-31 | $189,447,000 | reported | |
| FY 2024 | 2024-03-31 | $174,963,000 | reported | |
| FY 2023 | 2023-03-31 | $126,527,000 | reported | |
| FY 2022 | 2022-03-31 | $79,545,000 | reported | |
| FY 2021 | 2021-03-31 | $56,754,000 | reported | |
| FY 2019 | 2020-03-31 | $38,761,000 | reported | |
| FY 2018 | 2019-03-31 | $22,173,000 | reported | |
| FY 2017 | 2018-03-31 | $13,516,000 | reported |
Segments
Geography
LineFY2026ShareChange
United States$12.17M94%−5.0%
United Kingdom$800.00K6.2%−12.9%
Total$12.97M
Biological products, except diagnostic substances
Replimune Group, Inc. is the 33rd largest of the 176 covered companies the SEC files under this code, by market cap. SIC 2836
CompanyRevenueGrowthNet marginMarket cap
BEAMBeam Therapeutics Inc.$139.7M120.0%57.2%$2.5B
REPLReplimune Group, Inc. (this company)———$2.1B
VIRVir Biotechnology, Inc.$68.6M7.6%638.9%$2.1BRXRXRecursion Pharmaceuticals, Inc.$74.7M26.9%863.4%$2.1BBCRXBiocryst Pharmaceuticals Inc$874.8M94.1%30.2%$2.0BMAZEMaze Therapeutics, Inc.———$2.0BCOAGHemab Therapeutics Holdings, Inc.———$1.8BMESOMesoblast LtdFiscal 2025 figures———$1.7BIMCRImmunocore Holdings plc$400.0M29.0%8.9%$1.6BPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
Replimune Group, Inc. · CIK 1737953 · Engraved from SEC EDGAR